Abstract:Objective:To investigate the proton magnetic resonance spectroscopy(1H MRS) features of benign and malignant musculoskeletal system tumors in human and to explore its feasibility and application value in the differentiation diagnosis of musculoskeletal system tumors. Methods: 40 cases were included in the study in which there were 12 cases in benign tumor group and 28 cases in malignant tumor group respectively. MRI and in vivo 1H MRS were performed on all cases and in vitro 1H MRS of fresh samples were studied on 26 cases of soft tissue tumors. The 1H MRS features of all 40 cases were analyzed and the correlation study between in vivo 1H MRS findings and that of in vitro 1H MRS was performed. Cho/Cr and Lipid/Cr were calculated on workstation and a statistic test was done. We caculated the cell density of 36 tumors and performed Pearson correlation analysis between the cell density and Cho/Cr value. Results: The Cho/Cr value in the malignant tumor was larger than in the benign tumor, but the Lipid/Cr value was smaller than in the benign tumor. The differences of Cho/Cr value and Lipid/Cr value between malignant and benign soft tissue tumors were statistically significant(P0.01). In contrast to benign tumor group, in vitro 1H MRS revealed increased Cho, Lac and mI peak and decreased Lipid and Glc peak in 18 cases of the malignant tumor, as well as increased Ala, Glu, PC and Gly peak in 12 cases of the malignant tumors. In vivo 1H MRS changes of Cho and Lipid peak in the musculoskeletal system tumors was consistent with in vitro 1H MRS. The average cell density was 150/FOV in the malignant tumor group and 61/FOV in the benign tumor group respectively. The difference of the average cell density between the two groups was statistically significant. The value of the cell density had a significant positive correlation with the Cho/Cr value of tumors(r=0.882, P0.001). Conclusion: The benign and malignant musculoskeletal system tumors in human showed great difference in 1H MRS. In vivo 1H MRS findings demonstrated great consistence with that of in vitro 1H MRS. In vivo 1H MRS has high application value in the differentiation diagnosis of musculoskeletal system tumors.

In Vivo Hydrogen-1 Magnetic Resonance Spectroscopy Study of Human Intracranial Tumors.

Study of Magnetic Resonance Spectroscopy of Comnon Intracranial Tumors

In Vitro Brain Tumors: Initial Study Using High Resolution Magic Angle Spinning 1H MR Spectroscopy

Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.

Differential diagnosis in the intracranial diseases: Proton magnetic resonance spectroscopy study

Application of Proton MR Spectroscopy on Evaluation of Radiotherapy Treated Intracranial Tumors

Magnetic Resonance Spectroscopy in Differential Diagnosis of Brain Tumor

Study of 1H-Magnetic Resonance Spectroscopy in the Peritumoral Edema of Astrocytomas in Brain

Hydrogen Magnetic Resonance Spectroscopy in the Diagnosis of Musculoskeletal System Tumors

Gliomas findings on proton magnetic resonane spectroscopy imaging and its clinical application

Preliminary Study of Proton MR Spectroscopy in Distinguishing Benign from Malignant Intracranial Lesions and Predicting the Malignancy of Tumors

Clinical Application of ~1H MRS in the Diagnosis of Brain Tumors

Significance of MR Spectroscopy in the Classification of Intracranial Astrocytic Tumors

Characteristics of Multivoxel Proton MR Spectroscopy in Brain Tumors:Comparison of Histological Pathology

The Clinical Application of 1 HMRS in Brain Tumor

3.0T 1H-MR Spectroscopy Imaging in the Evaluation of Intracranial Tumors

Application of Hydrogen Proton Magnetic Resonance Spectroscopy in Diagnosis of Peripheral Tumor Cell Infiltration of Gliomas

1H-MR Spectroscopy of Bone and Soft Tissue Tumors with in Vivo

The Application of Multi-Voxel Magnetic Resonance Spectroscopy in Differentiating Gliomas from Solitary Intracranial Metastases

In Vivo MR Spectroscopy Characteristics of Rat C6 Glioma Model and Its Histology Apperance

Application Of Magnetic Resonance Spectroscopy In The Preoperative Grading Of Gliomas